NIH

Displaying 1 - 10 of 21


$8 million NIH grant awarded to Vanderbilt researchers for study of infant/child brain development

Two Vanderbilt faculty have received an $8 million grant from the National Institutes of Health as part of a groundbreaking, multi-institutional overview of variables influencing infant and child brain development, including substance exposure.


Landman awarded $2.6 million grant to improve Alzheimer’s patient management

An electrical and computer engineering professor has received a $2.6 million NIH grant to improve the understanding of structural changes in the brains of people who have Alzheimer’s Disease.


Team awarded $2.3 million NIH grant to evaluate new, more accurate ultrasound methods

New acquisition and reconstruction solutions for ultrasound imaging developed by a Vanderbilt team aim to fundamentally improve the ability to obtain high quality, clinically relevant images, especially in cases of heart disease.


VUMC begins study of second COVID-19 vaccine

Vanderbilt University Medical Center has begun recruiting up to 250 participants for a phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.


Discovery aids search for cancer biomarkers

A report by researchers at Vanderbilt University Medical Center has shattered conventional wisdom about how cells, including cancer cells, shed DNA into the bloodstream: they don’t do it by packaging the genetic material in tiny vesicles called exosomes.


New target for chronic kidney disease

The kidney has a remarkable capacity to repair itself following acute injury, but maladaptive repair can lead to fibrosis (scarring) and chronic kidney disease.